Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
Malignant melanoma demonstrates the highest rate of cardiac metastases. The incidence of melanoma is rising. The prognosis of people with advanced melanoma is generally poor. This case report emphasizes the potential need for early detection of cardiac involvement in advanced melanoma in view of pro...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | JACC: Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666084919300464 |
id |
doaj-8d570206f3e34025a468090742d30f24 |
---|---|
record_format |
Article |
spelling |
doaj-8d570206f3e34025a468090742d30f242021-06-07T06:53:59ZengElsevierJACC: Case Reports2666-08492019-06-011158Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab TreatmentFrederik Uttenthal Larsen, MD0Johannes Katate Wilhjelm, MD1Eric Steen Nielsen, MD2Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark; Address for correspondence: Dr. Frederik Uttenthal Larsen, Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.Department of Cardiology, Viborg Regional Hospital, Viborg, DenmarkDepartment of Cardiology, Viborg Regional Hospital, Viborg, DenmarkMalignant melanoma demonstrates the highest rate of cardiac metastases. The incidence of melanoma is rising. The prognosis of people with advanced melanoma is generally poor. This case report emphasizes the potential need for early detection of cardiac involvement in advanced melanoma in view of promising advances in treatment with immune checkpoint inhibitors. (Level of Difficulty: Advanced.)http://www.sciencedirect.com/science/article/pii/S2666084919300464cardio-oncologycardiovascular imagingcardiac metastasesimmune checkpoint inhibitors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Frederik Uttenthal Larsen, MD Johannes Katate Wilhjelm, MD Eric Steen Nielsen, MD |
spellingShingle |
Frederik Uttenthal Larsen, MD Johannes Katate Wilhjelm, MD Eric Steen Nielsen, MD Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment JACC: Case Reports cardio-oncology cardiovascular imaging cardiac metastases immune checkpoint inhibitors |
author_facet |
Frederik Uttenthal Larsen, MD Johannes Katate Wilhjelm, MD Eric Steen Nielsen, MD |
author_sort |
Frederik Uttenthal Larsen, MD |
title |
Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment |
title_short |
Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment |
title_full |
Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment |
title_fullStr |
Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment |
title_full_unstemmed |
Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment |
title_sort |
remission of a perimyocardial melanoma metastasis with pembrolizumab treatment |
publisher |
Elsevier |
series |
JACC: Case Reports |
issn |
2666-0849 |
publishDate |
2019-06-01 |
description |
Malignant melanoma demonstrates the highest rate of cardiac metastases. The incidence of melanoma is rising. The prognosis of people with advanced melanoma is generally poor. This case report emphasizes the potential need for early detection of cardiac involvement in advanced melanoma in view of promising advances in treatment with immune checkpoint inhibitors. (Level of Difficulty: Advanced.) |
topic |
cardio-oncology cardiovascular imaging cardiac metastases immune checkpoint inhibitors |
url |
http://www.sciencedirect.com/science/article/pii/S2666084919300464 |
work_keys_str_mv |
AT frederikuttenthallarsenmd remissionofaperimyocardialmelanomametastasiswithpembrolizumabtreatment AT johanneskatatewilhjelmmd remissionofaperimyocardialmelanomametastasiswithpembrolizumabtreatment AT ericsteennielsenmd remissionofaperimyocardialmelanomametastasiswithpembrolizumabtreatment |
_version_ |
1721392071572455424 |